In certain cancers, including cervical cancer, neoplastic cells may express the ligand PD-L1 (Programmed death-ligand 1), which, upon binding to PD-1, effectively "switches off" the T cell-mediated immune response. The gene discussed is CD274; the disease is cervical carcinoma.